Slide 1 Faculty Disclosure Mikayla Spangler, PharmD, BCPS Dr. Spangler has listed no financial interest/arrangement that would be considered a conflict of interest. Slide…
Slide 1 ADRENOCEPTOR ACTIVATING DRUGS AND OTHER SYMPATHOMIMETICS DEFINITION: Sympathomimetics are drugs that partially or completely mimic the action of EPINEPHRINE (E) or…
Slide 1 Bydureon ® Educate By Expert toolkit Scientific slides: GLP-1 receptor agonists and the discovery of exenatide GLP-1, glucagon-like peptide-1. Developed with the…
Slide 1Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes- 2013 ADA and AACE Guidelines: Room For Improvement (Be HAPPY/…
Slide 1 Comparing Medications for Adults With Type 2 Diabetes Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Slide 2 A chronic illness characterized…
Slide 1 Analgesic Drugs Department of Pharmacology Zhang Yan-mei Slide 2 Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli…
Slide 1 AIFA European Conference on Clinical Research for Decision Making Which Medicines Do We Need ? Thomas Lönngren, EMEA 30 March 2007 Slide 2 Content What are the health…
Theoretical and computational methods for the study of biological macromolecules Rachid C. Maroun, PhD Unité de Bioinformatique Structurale Institut Pasteur Paris, FRANCE…
DM IN THE NAME OF GOD Hypoglycemic Agents Recommendations: Glycemic Goals in Adults Hb A1C < 7% Hb A1C < 6.5% Hb A1C < 8% Recommendations: Glycemic Goals in Adults…